Footer

Pfizer, the world’s third-largest pharmaceutical company, recently announced that it is abandoning research for Alzheimer’s and Parkinson’s disease treatments. The decision, which will lay off hundreds of research positions throughout the pharmaceutical titan, crushes the hopes of millions suffering from these neurological disorders, and now their dreams of finding a medication won’t likely come to […]

The top drug in a large-scale Alzheimer’s disease collaboration between Biogen and Eisai has failed its first test, unable to reach its main goal in a mid-stage clinical trial. Biogen and Eisai announced today that an independent interim analysis at 12 months discovered the drug BAN2401 didn’t exhibit enough of a change on assessment scores […]

Medical professionals and researchers have yet to prove that any treatment, therapy or brain training can help prevent dementias like Alzheimer’s disease, a lengthy new review concludes. No medications, over-the-counter remedies or brain exercise programs have been proven in sophisticated clinical trials to prevent dementia, researchers with the Minnesota Evidence-Based Practice Center in Minneapolis states after […]

According to a new study conducted by researchers from the German Center for Neurodegenerative Diseases and the University of Bonn currently published in the journal Nature, inflammatory mechanisms caused by the brain’s immune system accelerate the progression of Alzheimer’s disease. These discoveries, made by a series of extensive laboratory experiments, give a new perspective on pathogenetic mechanisms […]

In an animal model of Alzheimer’s disease, a compound was able to prevent brain cells from dying; this may potentially lead to alternative treatment for individuals suffering from Alzheimer’s due to depression, memory loss, and progressively impaired cognitive ability. The journal Biological Psychiatry just published a report describing how an experimental compound known as P7C3-S243 […]

It’s estimated that 50 million people worldwide are living with Alzheimer’s disease. This number is rising slowly with the fast aging populations in several countries. Alzheimer’s is a deadly neurodegenerative disease that causes a progressive loss of cognitive function, ability to complete daily tasks and various levels of physical and emotional stress. Cells begin to lose […]

Alzheimer’s is a fatal neurodegenerative disease that results in the loss of a person’s cognitive function, ability to complete daily tasks and causes various degrees of physical and emotional stress. Here are 10 things you need to know about Alzheimer’s disease: The most common form of dementia is Alzheimer’s disease, which affects near 40 million […]

That has been no strong evidence to support that a nutrient drink sold online in the UK helps slows Alzheimer’s disease in its early stages, researchers claim. A recent trial revealed patients who consumed Souvenaid did not help aid memory loss and cognitive thinking. Authors of the paper say that larger studies are required to show […]

New research has revealed that amyloid beta, the protein that’s prevalent in Alzheimer’s diseased brains, could have originated from other body parts. The study published in the journal Molecular Psychiatry explains scientists surgically attached mice to each other for months to confirm that amyloid beta found in the bloodstream can go to the brain and creates common […]